Published in Malar J on January 14, 2010
Malaria in pregnancy. Mediterr J Hematol Infect Dis (2013) 1.11
Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination. BMC Infect Dis (2012) 0.83
Timing of malaria in pregnancy and impact on infant growth and morbidity: a cohort study in Uganda. Malar J (2016) 0.79
Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum. PLoS One (2015) 0.77
Ethnic differences in the accumulation of fat and lean mass in late gestation. Am J Hum Biol (2012) 0.76
Undernutrition and malaria in pregnancy - a dangerous dyad? BMC Med (2016) 0.75
Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ (1987) 16.26
Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med (2007) 13.43
The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med (1985) 12.23
Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis (2007) 10.66
Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science (1996) 10.03
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet (2008) 9.05
The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg (2001) 8.60
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet (2008) 8.50
The decline in paediatric malaria admissions on the coast of Kenya. Malar J (2007) 7.45
A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods. Malar J (2006) 6.32
Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg (2001) 4.83
Might efforts to increase birthweight in undernourished women do more harm than good? Lancet (1992) 4.26
The impact of placental malaria on gestational age and birth weight. J Infect Dis (2000) 4.25
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev (2004) 3.45
An analysis of anemia and pregnancy-related maternal mortality. J Nutr (2001) 3.27
The sick placenta-the role of malaria. Placenta (2004) 3.18
Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol (2000) 2.84
Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg (2003) 2.76
Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med (2005) 2.72
Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis (2008) 2.69
Changing pattern of malaria in Bissau, Guinea Bissau. Trop Med Int Health (2008) 2.54
Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health (2001) 2.05
Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg (2002) 2.03
Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial . BMJ (1997) 2.03
Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission. Am J Epidemiol (2001) 2.01
Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci U S A (2005) 1.95
Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol (1997) 1.94
Effects of intrauterine growth retardation on mortality and morbidity in infants and young children. Eur J Clin Nutr (1998) 1.91
Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med (2009) 1.87
The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg (2004) 1.86
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83
Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis (1999) 1.69
Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar J (2009) 1.63
Malaria chemoprophylaxis, birth weight and child survival. Trans R Soc Trop Med Hyg (1993) 1.50
Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. AIDS (2003) 1.46
Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. Exp Parasitol (2006) 1.44
Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection. J Infect Dis (2005) 1.40
Determinants of low birth weight: a community based prospective cohort study. Indian Pediatr (1994) 1.38
Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens. Mol Biochem Parasitol (2006) 1.37
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One (2007) 1.33
Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta. Infect Immun (2002) 1.29
Early immunological development and mortality from infectious disease in later life. Proc Nutr Soc (2006) 1.16
Pregnancy outcomes in women with or without placental malaria infection. Int J Gynaecol Obstet (2006) 1.11
Anaemia- and malaria-attributable low birthweight in two populations in Papua New Guinea. Ann Hum Biol (1997) 1.08
Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. Am J Trop Med Hyg (2003) 1.07
Maternally transmitted antibodies to pregnancy-associated variant antigens on the surface of erythrocytes infected with Plasmodium falciparum: relation to child susceptibility to malaria. Am J Epidemiol (2003) 1.06
Malaria during pregnancy: parasites, antibodies and chondroitin sulphate A. Biochem Soc Trans (1999) 1.02
Fetal responses during placental malaria modify the risk of low birth weight. Infect Immun (2008) 1.00
Fetal growth influences lymphocyte subset counts at birth: the Generation R Study. Neonatology (2008) 0.96
The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth. Eur J Immunol (2010) 0.95
Mean maternal second-trimester hemoglobin concentration and outcome of pregnancy: a population-based study. Clin Appl Thromb Hemost (2008) 0.94
Catch-up growth in Malawian babies, a longitudinal study of normal and low birthweight babies born in a malarious endemic area. Early Hum Dev (2005) 0.94
Plasmodium falciparum infection of the placenta impacts on the T helper type 1 (Th1)/Th2 balance of neonatal T cells through CD4(+)CD25(+) forkhead box P3(+) regulatory T cells and interleukin-10. Clin Exp Immunol (2009) 0.93
Influence of birth weight on mortality from infectious diseases: a case-control study. Pediatrics (1988) 0.93
High prevalence of placental malaria and low birth weight in Sahelian periurban area. Am J Trop Med Hyg (2006) 0.93
Low birthweight associated with maternal anaemia and Plasmodium falciparum infection during pregnancy, in a peri-urban/urban area of low endemicity in Uganda. Ann Trop Med Parasitol (2000) 0.92
What does it take to control malaria? Ann Trop Med Parasitol (2007) 0.91
Malaria as a cause of severe anaemia in pregnancy. Lancet (2002) 0.83
Physiological and pathological regulation of feto/placento/maternal leptin expression. Biochem Soc Trans (2001) 0.82
Sequestration: causes and consequences. Redox Rep (2003) 0.79
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med (2003) 6.25
Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis (2011) 5.02
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog (2008) 3.79
Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. J Infect Dis (2009) 2.64
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med (2011) 2.59
Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States. Clin Diagn Lab Immunol (2004) 2.58
Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ (2010) 2.52
Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J (2012) 2.46
Progress towards a dengue vaccine. Lancet Infect Dis (2009) 2.45
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A (2003) 2.33
Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol (2007) 2.28
Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS (2007) 2.24
Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol (2004) 2.24
Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ (2010) 2.18
Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2. Int J Epidemiol (2006) 2.05
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol (2002) 1.98
An epidemiological study of RSV infection in the Gambia. Bull World Health Organ (2002) 1.97
Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci Transl Med (2011) 1.94
Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ (2008) 1.91
Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J Infect (2009) 1.89
Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest (2003) 1.85
Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res (2010) 1.80
The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ (2004) 1.76
Dietary patterns in infancy: the importance of maternal and family influences on feeding practice. Br J Nutr (2007) 1.76
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales. Clin Infect Dis (2013) 1.66
Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J Virol (2005) 1.60
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J Immunol (2005) 1.60
HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. J Infect Dis (2009) 1.57
Recombination following superinfection by HIV-1. AIDS (2004) 1.57
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. PLoS One (2011) 1.52
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene (2005) 1.49
20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.44
Fetal liver-sparing cardiovascular adaptations linked to mother's slimness and diet. Circ Res (2004) 1.43
Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol (2010) 1.42
Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood (2002) 1.39
Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. AIDS (2004) 1.38
Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum (2006) 1.38
Antiretroviral treatment in resource-poor settings: public health research priorities. Trop Med Int Health (2005) 1.37
Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J Immunol (2006) 1.36
Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med (2007) 1.36
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One (2007) 1.33
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin Vaccine Immunol (2009) 1.30
Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians. Virol J (2010) 1.29
The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination. Vaccine (2009) 1.28
Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol (2005) 1.28
Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child (2012) 1.28
Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine (2011) 1.27
The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis. Dtsch Arztebl Int (2014) 1.26
Evaluation of the dried blood spot filter paper technology and five testing strategies of HIV-1 and HIV-2 infections in West Africa. Scand J Infect Dis (2006) 1.26
Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 1.26
Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis (2011) 1.25
High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. PLoS One (2007) 1.25
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. PLoS One (2008) 1.25
A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls. PLoS One (2013) 1.23
Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom. Pediatr Infect Dis J (2010) 1.23
Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS One (2011) 1.22
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect (2008) 1.22
Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study. PLoS One (2008) 1.19
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS One (2008) 1.16
Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. J Infect Dis (2008) 1.15
A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nat Genet (2004) 1.13
HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children. PLoS Pathog (2012) 1.13
Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants. J Clin Microbiol (2009) 1.12
Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. Lancet (2002) 1.12
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev (2005) 1.12
A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS (2008) 1.11
Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hum Retroviruses (2004) 1.11
Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia. AIDS (2006) 1.10
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom. Clin Vaccine Immunol (2008) 1.10
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One (2013) 1.10
The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis (2009) 1.09
Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine. Am J Clin Nutr (2007) 1.09
Analysis of flow cytometry data using an automatic processing tool. Cytometry A (2008) 1.09
Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study. BMC Infect Dis (2013) 1.08